Trial NCT04381936, EudraCT 2020-001113-21, ISRCTN5018967
Publication Horby P(2), medRxiv, 2021 (preprint)
Dates: 2020-09-18 to 2021-05-22
Funding: Mixed (UK Research and Innovation (Medical Research Council); National Institute of Health Research; Regeneron Pharmaceuticals Inc. (REGEN-COV2 donation))
Conflict of interest: Yes